Characterization of preferential activity on platelet thromboxane A2 receptors of BM-613, a new thromboxane A2 antagonist

Hanson, Julien; Rolin, S.; De Leval, X.; Neven, P.; Masereel, B.; Pirotte, Bernard; Dogné, Jean-Michel

Paper published in a journal (Scientific congresses and symposiums)

Hanson, Julien; Rolin, S.; De Leval, X. et al.

2004 • In Fundamental and Clinical Pharmacology, p. 269

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/21976

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Fund. Clin. Pharm. 2004, 18, 269-271.pdf

Publisher postprint (88.61 kB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

Pharmacy, pharmacology & toxicology

Author, co-author :

Hanson, Julien ; Université de Liège - ULiège > Département de pharmacie > Chimie pharmaceutique

Rolin, S.

De Leval, X.

Neven, P.

Masereel, B.

Pirotte, Bernard ; Université de Liège - ULiège > Département de pharmacie > Chimie pharmaceutique

Dogné, Jean-Michel ; Université de Liège - ULiège > Département de pharmacie > Département de pharmacie

Language :

English

Title :

Characterization of preferential activity on platelet thromboxane A2 receptors of BM-613, a new thromboxane A2 antagonist

Publication date :

2004

Audience :

International

Journal title :

Fundamental and Clinical Pharmacology

ISSN :

0767-3981

eISSN :

1472-8206

Publisher :

Blackwell Science, Oxford, United Kingdom

Special issue title :

Pages :

269

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 11 September 2009

Statistics

Number of views

51 (1 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics